Nyrada Inc.
ASX:
NYR
Nyrada, Inc. is a pre-clinical stage, drug discovery, and development company, which engages in the business of specializing in novel small molecule drugs to treat cardiovascular and neurological diseases. The firm also focuses on developing an oral, small molecule chole
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
PG Weekly Pick
A$100.00
Already a subscriber?
Sign in to read this report.
Required subscription
PG Weekly Pick
Receive one high-conviction ASX stock idea every week, backed by detailed research, risk analysis, and a clear investment thesis designed to help you focus on quality opportunities.
- ✓ One Premium ASX Stock Pick Weekly
- ✓ Delivered Every Friday
- ✓ Buy / Hold / Sell Guidance & Risk Rating
- ✓ Full Historical Pick Access
A$100.00/ 1 months
Risk:High
Subscribe Now →
